APICES attended the most important annual Biotechnology congress, BIO International Convention, which took place between June 3 and June 6 in the city of San Diego (CA – USA). The BIO International Convention is the largest and most…
This month, we want to share the acknowledgment that APICES has received in the recent publication of HEMOLIFE Study: Humanistic burden of haemophilia Awithout inhibitors: A cross-sectional analysis of the HEMOLIFE study, published in Haemophilia in which APICES has…
APICES corporate video is available on the Clinical Trials Arena website Hi everybody, APICES corporate video is now also available on the Clinical Trials Arena website. Enjoy it! https://www.clinicaltrialsarena.com/contractors/clinical-trials/apices/#apices (select tab “videos”)
Spanish CRO APICES boosts its expansion and growth plans with the integration of the French CRO Kappa Santé. With this operation, the Spanish company will have offices in Paris (France), consolidating its growth and fostering collaboration with other research…
This month, we want to share the acknowledgment that APICES has received in the recent publication titled “A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the Geminis study”
First Congress Fundación Española de Tratamiento de Tumores de Cabeza y Cuello It is a pleasure for APICES to cooperate with this multidisciplinary congress in head and neck cancer where clinical research is a must. Congrats to organisers,…
APICES approved by French Ministry of Research as research organization. We are very happy to inform you that APICES has applied to the French Ministry of Research as an organisation carrying out research and development (R&D) and this…
Acknowledgement for APICES collaboration in ABACUS trial published in “European Urology” Once more time we are privileged to share the acknowledgment that APICES has received in the recent publication titled: “Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients…
Acknowledgement for APICES collaboration in DART 01/05 study published in “The Lancet Oncology” Once more time we are privileged to share the acknowledgment that APICES has received in the recent publication titled: “High-dose radiotherapy and risk-adapted androgen deprivation…
NEW DATA PROTECTION CODE OF CONDUCT BY EUCROF Procedure and technical measures in order to comply with General Data Protection Regulation 2016/679 are being more and more standardized through codes of conduct in several fields. Until now, there…
